Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma

European Journal of Immunology

Volumn 35, Issue 4, 2005, Pages 1076-1085

  Archambault, Angela S ^a   Sim, Julia ^a   Gimenez, Mary Ann T ^a   Russell, John H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; EAE MS 7 cell trafficking; MHC; T cells

Indexed keywords

CD4 ANTIGEN; CD4 IMMUNOGLOBULIN; CONCANAVALIN A; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BLOOD; BRAIN BLOOD VESSEL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBARACHNOID SPACE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

ANIMALS; ANTIGENS; BLOOD; BLOOD-BRAIN BARRIER; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM; ENDOTHELIUM, VASCULAR; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES;

EID: 17444382009     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425864     Document Type: Article

References (34)

1. Lucchinetti, C. F., Bruck, W., Rodriguez, M. and Lassmann, H., Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol. 1996. 6: 259-274.
2. Noseworthy, J. H., Lucchinetti, C., Rodriguez, M. and Weinshenker, B. G., Multiple Sclerosis. N. Engl. J. Med. 2000. 343: 938-952.
3. Raine, C. S., Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab. Invest. 1984. 50: 608-635.
4. Andon D. G., Clayton, J., Kono, D., Urban, J. L. and Sercarz, E. E., Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol. 1989. 124: 132-143.
5. Bernard, C. C. and Carnegie, P. R., Experimental autoimmune encephalomyelitis in mice: immunologic response to mouse spinal cord and myelin basic proteins. J. Immunol. 1975. 114: 1537.
6. Zamvil, S. S., Nelson, P. A., Mitchell, D. J., Knobler, R. L., Fritz, R. B. and Steinman, L., Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition. J. Exp. Med. 1985. 162: 2107-2124.
7. Merrill, J. E. and Benveniste, E. N., Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 1996. 19: 331-338.
8. Lossinsky, A. S., Shivers, R.R., Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Rev. Histol. Histopathol. 2004. 19: 535-564.
9. Ransohoff, R. M., Kivisakk, P. and Kidd, G., Three or more routes for leukocyte migration into the CNS. Nat. Rev. Immunol. 2003. 3: 569-581.
10. Owens, T., Tran, E., Hassan-Zahraee, M. and Krakowski, M., Immune cell entry to the CNS - a focus for immunoregulation of EAE. Res. Immunol. 1998. 149: 781-789.
11. Flugel, A., Berkowicz, T., Ritter, T., Labeur, M., Jenne, D. E., Li, Z., Ellwart, J. W., Willem, M., Lassmann, H. and Wekerle, H., Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 2001. 14: 547-560.
12. Piccio, L., Rossi, B., Scarpini, E., Laudanna, C., Giagulli, C., Issekutz, A. C., Vestweber, D., Butcher, E. C. and Constantin, G., Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric Gi-linked receptors. J. Immunol. 2002. 168: 1940-1949.
13. Hickey, W., Hsu, B. L. and Kimura, H., T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 1991. 28: 254-260.
14. Ludowyk, P. A., Willenborg, D. O. and Parish, C. R., Selective localisation of neuro-specific T lymphocytes in the central nervous system. J. Neuroimmuno. 1992. 37: 237-250.
15. Graesser, D., Solowiej, A., Bruckner, M., Osterweil, E., Juedes, A., Davis, S., Ruddle, N. H., Engelhardt, B. and Madri, J. A., Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J. Clin. Invest. 2002. 109: 383-392.
16. Vajkoczy, P., Laschinger, M. and Engelhardt, B., α4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J. Clin. Invest. 2001. 108: 557-565.
17. Gimenez, M. A. T., Sim, J. E. and Russell, J. H., TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation. J. Neuroimmunol. 2004. 151: 116-125.
18. Pakala, S. V., Chivetta, M., Kelly, C. B. and Katz, J. D., In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha J. Exp. Med. 1999. 189: 1053-1062.
19. Ghobrial, R. R., Boublik, M., Winn, H. J. and Auchincloss, H., Jr., In vivo use of monoclonal antibodies against murine T cell antigens. Clin. Immunol. Immunopathol. 1989. 52: 486-506.
20. Tompkins, S. M., Padilla, J., Dal Canto, M. C., Ting, J. P.-Y., Van Kaer, L. and Miller, S. D., De novo central nervous system pProcessing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 2002. 168: 4173-4183.
21. Farrar, J. D., Asnagli, H. and Murphy, K. M., T helper subset development: roles of instruction, selection, and transcription. J. Clin. Invest. 2002. 109: 431-435.
22. Wekerle, H., Linington, C., Lassmann, H. and Meyermann, R., Cellular immune reactivities within the CNS. Trends Neurosci. 1986. 9: 271-277.
23. Janeway, C. A. and Medzhitov, R., Innate immune recognition. Annu. Rev. Immunol. 2002. 20: 197-216.
24. Barten, D. M. and Ruddle, N. H., Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol. 1994. 51: 123-133.
25. Dopp, J. M., Breneman, S. M. and Olschowka, J. A., Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis. J. Neuroimmunol. 1994. 54: 129-144.
26. Juedes, A. E., Hjelmstrom, P., Bergman, C. M., Neild, A. L. and Ruddle, N. H., Kinetics and cellular origin of cytokines in the central nervous system: Insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 2000. 164: 419-426.
27. Ransohoff, R. M., Hamilton, T. A., Tani M, Stoler, H. E., Shick, J. A., Major, M. L., Estes, D. M., Thomas, D. M. and Tuohy, V. K., Astrocyte expression of mRNA encoding cytokines IP-10 and JE /MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 1993. 7: 592-600.
28. Graesser, D., Mahooti, S. and Madri, J. A., Distinct roles for matrix metalloproteinase-2 and α4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis. J.f Neuroimmunol. 2000. 109: 121-131.
29. Train, E. H., Hoekstra, K., Van Rooijen, N., Dijkstra, C. D. and Owens, T., Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J. Immunol. 1998. 161: 3767-3775.
30. + T lymphocyte-induced target cell detachment. A model for T cell-mediated lytic and nonlytic inflammatory processes. J. Immunol. 1991. 146: 405-413.
31. Pala, P., Hussell, T. and Openshaw, P. J. M., Flow cytometric measurement of intracellular cytokines. J. Immunol. Methods 2000. 243: 107-124.
32. Cohen, J. A., Essayan, D. M., Zweiman, B. and Lisak, R. P., Limiting dilution analysis of the frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis. Cell. Immunol. 1987. 108: 203-213.
33. Irani, D. N. and Griffin, D. E., Isolation of brain parenchymal lymphocytes for flow cytometric analysis. Application to acute viral encephalitis. J. Immunol. Methods 1991. 139: 223-231.
34. Vandenbark, A. A., Vainiene, M., Celnik, B., Hashim, G. and Offner, H., TCR peptide therapy decreases the frequency of encephalitogenic T cells in the periphery and the central nervous system. J. Neuroimmunol. 1992. 39: 251-260.